← All patents

US20170342078A1

Heterocyclic inhibitors of ptpn11

University of Texas System

Abstract

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Philip Jones
Priority date
May 31, 2016
Filing date
May 26, 2017
Publication date
November 30, 2017
Language
en
Metadata fetched
August 29, 2026 00:24